Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -8.23%232.14M | -16.64%177.52M | 2.70%238.55M | 37.25%918.29M | 2.91%220.11M | 38.28%252.96M | 59.55%212.96M | 67.41%232.27M | 12.46%669.04M | 59.55%213.88M |
| Cost of revenue | -13.38%161.25M | -11.35%126.26M | -1.32%170.64M | 43.95%669.97M | 16.04%168.57M | 46.38%186.16M | 55.24%142.43M | 70.84%172.92M | 9.87%465.41M | 54.15%145.28M |
| Gross profit | 6.11%70.88M | -27.32%51.26M | 14.42%67.91M | 21.95%248.32M | -24.87%51.54M | 19.79%66.8M | 69.02%70.53M | 58.15%59.35M | 18.87%203.63M | 72.33%68.61M |
| Operating expense | 26.64%36.23M | -27.24%23.69M | 9.71%37.14M | 36.11%128.56M | 31.71%38.47M | 15.84%28.61M | 47.62%32.55M | 66.67%33.85M | 12.48%94.45M | 27.20%29.21M |
| Selling and administrative expenses | 26.64%36.23M | -27.24%23.69M | 9.71%37.14M | 37.89%116.2M | 31.71%38.47M | 15.84%28.61M | 47.62%32.55M | 66.67%33.85M | 17.56%84.27M | 173.63%29.21M |
| -Selling and marketing expense | 1.50%9.25M | 10.39%7.55M | 1.17%8.11M | 50.88%31.8M | 39.90%7.83M | 73.32%9.12M | 21.90%6.84M | 73.91%8.01M | 10.30%21.08M | 47.15%5.6M |
| -General and administrative expense | 38.39%26.98M | -37.25%16.13M | 12.36%29.03M | 33.56%84.4M | 29.77%30.64M | 0.29%19.49M | 56.40%25.71M | 64.54%25.83M | 20.19%63.19M | 243.62%23.61M |
| Other operating expenses | ---- | ---- | ---- | 21.42%12.37M | ---- | ---- | ---- | ---- | -17.12%10.19M | ---- |
| Operating profit | -9.26%34.66M | -27.39%27.57M | 20.68%30.78M | 9.69%119.75M | -66.82%13.07M | 22.93%38.19M | 93.00%37.98M | 48.11%25.5M | 25.00%109.17M | 133.84%39.4M |
| Net non-operating interest income (expenses) | 4.49%-6.08M | -11.64%-6.99M | 16.69%-5.94M | -17.59%-24.83M | 10.58%-5.1M | 16.85%-6.37M | -37.78%-6.27M | -122.09%-7.13M | -87.26%-21.12M | -46.43%-5.7M |
| Non-operating interest expense | -4.49%6.08M | 11.64%6.99M | -16.69%5.94M | 17.59%24.83M | -10.58%5.1M | -16.85%6.37M | 37.78%6.27M | 122.09%7.13M | 87.26%21.12M | 46.43%5.7M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 18.83%-125K | -441.67%-123K | -5.63%-75K | -206.42%-301.18K | -1,162.50%-101K | -216.67%-154K | -23.40%36K | -163.39%-71K | -6.59%283.01K | -111.77%-8K |
| Special income (charges) | -151.05%-4.55M | -7.95%-1.81M | ||||||||
| Less:Write off | ---- | ---- | ---- | 151.05%4.55M | ---- | ---- | ---- | ---- | 7.95%1.81M | ---- |
| Other non-operating income (expenses) | 71.50%981K | -24.33%653K | 37.58%1.92M | 8.27%5.14M | 104.94%2.82M | -56.50%572K | -12.39%863K | 29.95%1.4M | 11.44%4.75M | -12.73%1.38M |
| Income before tax | -8.73%29.43M | -35.27%21.11M | 35.45%26.68M | 4.31%95.22M | -69.50%10.7M | 29.72%32.24M | 101.77%32.61M | 29.64%19.7M | 15.62%91.28M | 171.36%35.07M |
| Income tax | 2.52%9.28M | -34.89%5.08M | 120.98%8.02M | -0.31%23.54M | -61.49%3.06M | 28.85%9.05M | 80.30%7.81M | -16.08%3.63M | 18.13%23.61M | 71.71%7.94M |
| Net income | -13.12%20.15M | -35.38%16.03M | 16.15%18.67M | 9.18%71.68M | -71.84%7.64M | 30.06%23.19M | 120.14%24.8M | 70.58%16.07M | 19.27%65.65M | 322.30%27.13M |
| Net income continuous operations | -13.12%20.15M | -35.38%16.03M | 16.15%18.67M | 5.93%71.68M | -71.84%7.64M | 30.06%23.19M | 109.63%24.8M | 47.82%16.07M | 14.77%67.66M | 226.89%27.13M |
| Net income discontinuous operations | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | 48.51%-2.02M | --0 |
| Noncontrolling interests | 22.72%4.28M | -98.35%93K | 31.49%5.17M | -4.99%12.31M | -106.94%-494K | 42.87%3.49M | 117.33%5.64M | 394.71%3.93M | 135.63%12.95M | 299.43%7.12M |
| Net income attributable to the company | -19.45%15.87M | -16.83%15.93M | 11.18%13.5M | 12.67%59.37M | -59.34%8.13M | 28.03%19.71M | 120.98%19.16M | 40.75%12.14M | 6.36%52.69M | 331.09%20M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -19.45%15.87M | -16.83%15.93M | 11.18%13.5M | 12.67%59.37M | -59.34%8.13M | 28.03%19.71M | 120.98%19.16M | 40.75%12.14M | 6.36%52.69M | 331.09%20M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -19.61%0.0041 | -16.33%0.0041 | 12.90%0.0035 | 12.50%0.0153 | -59.62%0.0021 | 27.50%0.0051 | 113.04%0.0049 | 40.91%0.0031 | 6.25%0.0136 | 300.00%0.0052 |
| Diluted earnings per share | -19.61%0.0041 | -16.33%0.0041 | 12.90%0.0035 | 12.50%0.0153 | -59.62%0.0021 | 27.50%0.0051 | 113.04%0.0049 | 40.91%0.0031 | 6.25%0.0136 | 332.25%0.0052 |
| Dividend per share | 0.00%0.005 | 0 | 0 | 244.98%0.023 | 0.008 | 0.005 | 0 | 49.99%0.01 | -9.08%0.0067 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.